AI assistant
Sending…
VERACYTE, INC. — Director's Dealing 2018
Aug 10, 2018
31551_dirs_2018-08-10_78f4c42a-3d3b-4d3e-85cc-6cc7fd242ab2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VERACYTE, INC. (VCYT)
CIK: 0001384101
Period of Report: 2018-08-09
Reporting Person: Hall Christopher M (President and COO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-08-09 | Common Stock | M | 4237 | $2.36 | Acquired | 36692 | Direct |
| 2018-08-09 | Common Stock | M | 8263 | $2.36 | Acquired | 44955 | Direct |
| 2018-08-09 | Common Stock | M | 7500 | $2.36 | Acquired | 52455 | Direct |
| 2018-08-09 | Common Stock | S | 20000 | $12 | Disposed | 32455 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-08-09 | Stock Option (right to buy) | $2.36 | M | 4237 | Disposed | 2020-09-27 | Common Stock (4237.0) | Direct |
| 2018-08-09 | Stock Option (right to buy) | $2.36 | M | 8263 | Disposed | 2010-09-27 | Common Stock (8263.0) | Direct |
| 2018-08-09 | Stock Option (right to buy) | $2.36 | M | 7500 | Disposed | 2021-02-22 | Common Stock (7500.0) | Direct |
Footnotes
F1: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 25, 2018.
F2: The option becomes exercisable as to 25% of the shares on September 28, 2011, and the remaining shares vested at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.
F3: The option became exercisable in full upon the date of the grant on February 23, 2011.
More from VERACYTE, INC.
Interim / Quarterly Report
2026
May 6
Proxy Solicitation & Information Statement
2026
Apr 22
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 25